Table 1 Distribution of sample size and disease activity scores in the low and high activity groups of each immune-mediated inflammatory disease (IMID) after quality control
From: Urine metabolome profiling of immune-mediated inflammatory diseases
IMID | Disease activity score | Discovery cohort | Validation cohort | ||
|---|---|---|---|---|---|
Low activitya | High activitya | Low activitya | High activitya | ||
CD | Harvey-Bradshaw Index [71] | 154 (0.0) | 45 (7.0) | 100 (0.0) | 100 (9.0) |
UC | Lichtiger Score [72] | 124 (0.0) | 81 (6.0) | 99 (0.0) | 98 (5.0) |
RA | Disease Activity Score 28 [73] | 114 (1.7) | 127 (5.5) | 98 (1.6) | 95 (5.6) |
PsA | Disease Activity Score 28 [73] | 97 (1.5) | 89 (3.9) | 96 (1.5) | 96 (4.2) |
Ps | Psoriasis Area Severity Index [74] | 101 (0.0) | 84 (14.1) | 100 (0.0) | 92 (17.5) |
SLE | 123 (1.0b) | 41 (11.0b) | 90 (1.0b) | 88 (7.5b) | |